Edgewise Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACET
|
Adicet Bio, Inc. | $1.43 | $110.93 M | -0.46 | 143 | $0 |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $6.12 | $291.95 M | -3.13 | 54 | $0 |
 CCCC
|
C4 Therapeutics, Inc. | $6.01 | $320.64 M | -1.97 | 145 | $20.76 M |
 CELC
|
Celcuity Inc. | $15.56 | $501.59 M | -5.14 | 55 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $17.97 | $1.29 B | -7.16 | 85 | $0 |
 DBTX
|
Decibel Therapeutics, Inc. | $4.91 | $123.37 M | -1.93 | 68 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.21 | $217.51 M | -3.7 | 57 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $7.87 | $258.33 M | -17.08 | 9 | $0 |
 HOWL
|
Werewolf Therapeutics, Inc. | $2.25 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 IPSC
|
Century Therapeutics, Inc. | $1.55 | $244.54 M | -1.32 | 152 | $2.24 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.66 | $652.38 M | -6.03 | 28 | $0 |
 PASG
|
Passage Bio, Inc. | $0.78 | $73.04 M | -0.77 | 58 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $41.65 | $6.66 B | -10.51 | 443 | $11.58 M |
 TALS
|
Talaris Therapeutics, Inc. | $2.72 | $116.44 M | -1.56 | 84 | $0 |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |
 VOR
|
Vor Biopharma Inc. | $1.06 | $83.62 M | -0.69 | 168 | $0 |
 XLO
|
Xilio Therapeutics, Inc. | $0.75 | $38.76 M | -0.41 | 73 | $0 |